Drummond Paris serves as Chairman of the Board at The Electrospinning Company. He has an impressive record of business achievements. After early experience in Pharmaceutical Sales, Sales Management , Marketing and Clinical Research, he was appointed to a number of increasingly senior management positions in the Pharmaceutical Industry with Sandoz and Novartis. More recently, in non-executive chairmanship roles, he lead the Board in supporting management to build an attractive medical technology business to guide an early stage, medical technology Company (Sirigen) towards a trade-sale exit where business was acquired by Becton Dickinson. He served as Co-Chairman at Karus Therapeutics.